Skip to main content

Medroxyprogesterone News

Prolonged Use of Progestogens May Raise Risk for Intracranial Meningioma

FRIDAY, March 29, 2024 – Prolonged use of medrogestone, medroxyprogesterone acetate, and promegestone is associated with an increased risk for intracranial meningioma, according to a study published...

Hormonal Meds for Birth Control, Menopause Linked to Brain Tumors

THURSDAY, March 28, 2024 – The contraceptive injection Depo-Provera and two drugs used for menopause relief could be linked to a heightened risk for brain tumors in some women, a new study warns....

FDA Medwatch Alert: Olympia Pharmacy Sterile Compounded Products: Recall - Concerns About Sterility Assurance

  [Posted 05/30/2013] ISSUE: Lowlite Investments d/b/a Olympia Pharmacy ("Lowlite") notified the public of a voluntary multi-state recall of all sterile drug products compounded by the pharmacy that ...

FDA Medwatch Alert: Qualitest Pharmaceuticals Oral Contraceptives: Recall - Packaging Error

includes Cyclafem 7/7/7, Cyclafem 1/35, Emoquette, Gildess FE 1.5/30, Gildess FE 1/20, Orsythia, Previfem, Tri-Previfem ISSUE: Qualitest Pharmaceuticals issued a nationwide, retail-level recall of...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Abnormal Uterine Bleeding, Endometrial Cancer, Contraception, Birth Control, Endometriosis, Renal Cell Carcinoma

Related drug support groups

Depo-Provera, Provera

Medroxyprogesterone patient information at Drugs.com